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Abstract 
Background 
Marinesco-Sjögren Syndrome (MSS) is a rare neuromuscular condition caused by recessive 
mutations in the SIL1 gene resulting in the absence of functional SIL1 protein, a co-chaperone 
for the major ER chaperone, BiP. As BiP is decisive for proper protein processing, loss of SIL1 
results in the accumulation of misshaped proteins. This accumulation likely damages and 
destroys cells in vulnerable tissues, leading to congenital cataracts, cerebellar ataxia, vacuolar 
myopathy and other MSS phenotypes. Whether the peripheral nervous system (PNS) is 
affected in MSS has not been conclusively shown.  
Methods 
To study PNS vulnerability in MSS, intramuscular nerves fibres from MSS patients and from 
SIL1-deficient mice (woozy) as well as sciatic nerves and neuromuscular junctions (NMJ) from 
these mice have been investigated via transmission electron microscopic and 
immunofluorescence studies accompanied by transcript studies and unbiased proteomic 
profiling. In addition, PNS and NMJ integrity were analyzed via immunofluorescence studies in 
an MSS-zebrafish model which has been generated for that purpose.  
Results 
Electron microscopy revealed morphological changes indicative of impaired autophagy and 
mitochondrial maintenance in distal axons and in Schwann cells. Moreover, changes of the 
morphology of NMJs as well as of transcripts encoding proteins important for NMJ function were 
detected in woozy mice. These findings were in line with a grossly abnormal structure of NMJs 
in SIL1-deficient zebrafish embryos. Proteome profiling of sciatic nerve specimens from woozy 
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mice revealed altered levels of proteins implicated in neuronal maintenance suggesting the 
activation of compensatory mechanisms.  
Conclusion 
Taken together, our combined data expand the spectrum of tissues affected by SIL1-loss and 
suggest that impaired neuromuscular transmission might be part of MSS pathophysiology. 
 
Keywords 
SIL1, Marinesco-Sjögren syndrome, woozy, PNS pathology, neuromuscular junction 
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Background 
Marinesco-Sjögren syndrome (MSS; MIM:248800) is a rare autosomal recessive disorder that 
affects multiple organ systems. Common symptoms of MSS are congenital cataracts, cerebellar 
ataxia, hypotonia, progressive muscle weakness, and delayed psychomotor development [1-4]. 
The disease affects males and females equally; however, the exact incidence of the disorder in 
the general population is unknown. MSS is often caused by mutations of the SIL1 gene which 
locates on the long arm of chromosome 5 (5q31.2) [5, 6]. SIL1, an adenine nucleotide exchange 
factor, binds to the 78 kDa glucose-regulated protein (GRP78; BiP) and thereby regulates its 
ATPase cycle. BiP belongs to the heat shock protein (HSP) 70 chaperone family and plays a 
key role in protein quality control within the endoplasmic reticulum (ER) [7, 8]. Loss of functional 
SIL1 results in the build-up of misfolded proteins in the ER and thus to activation of the unfolded 
protein response (UPR) and likely damages cells in many tissues, leading to congenital or 
infantile cataracts, Purkinje cell degeneration and ataxia, progressive vacuolar myopathy and 
other phenotypes such as MSS complicated by Dandy-Walker syndrome [9], by spastic 
paraplegia [10] or by motor neuronopathy and bradykinetic movement disorder [11]. Overall, this 
phenotype highlights an important role of SIL1 in neuronal function and maintenance. In woozy 
mice, loss of functional SIL1 results in ER-stress, UPR activation and Purkinje cell degeneration 
and vacuolar myopathy with signs of altered autophagy and typical alterations of the 
myonuclear envelope, indicating that the woozy mouse is a suitable phenocopy of the human 
disease [12-15].  
In the nervous system, ER stress has been identified as a key process in multiple 
neurodegenerative conditions such as Alzheimer's and Parkinson's disease, Amyotrophic 
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Lateral Sclerosis (ALS) and prion diseases [16, 17]. In this context, it is important to note that 
apart from the above described MSS phenotype, a prominent role of SIL1 in maintaining 
integrity and function of the nervous system is suggested by the following observations: (i) SIL1 
has been described as a disease-modifying protein in ALS and Alzheimer's disease, 
respectively [18, 19], (ii) in vitro overexpression of SIL1 resulted in elevation of a variety of 
proteins with neuroprotective functions [20], (iii) in vitro depletion of SIL1 affects several proteins 
important for neuronal function [21] and (iv) morphological studies of Sil1-mutant mice revealed 
pathological alterations of nerve terminals and neuromuscular junctions along with signs of 
neurogenic muscular atrophy [18]. Although Horvers and co-workers found no clear evidence of 
peripheral neuropathy in their cohort of four Dutch MSS patients with proven SIL1 mutations 
[22]; still, the evidence discussed above suggests a vulnerability of the PNS against loss of 
functional SIL1. However, so far there is no dedicated study focusing on the effect of SIL1 
deficiency on peripheral nerves and neuromuscular junctions (NMJs). To systematically address 
this question, we investigated intramuscular nerve fascicles in MSS-patients and woozy mice as 
well as the sciatic nerves of these mice by transmission electron microscopy. Moreover, 
proteomic profiling of the murine sciatic nerve was performed to obtain insights into the 
biochemical consequences of loss of the SIL1 protein in the PNS. Finally, NMJs were 
systematically studied by immunofluorescence in Sil1-mutant and wildtype mice as well as in an 
MSS-zebrafish model.  
 
Materials and Methods 
Electron microscopy 
Ultrathin sections of archived glutaraldehyde-fixed, resin-embedded M. quadriceps biopsies 
obtained from two MSS-patients with proven SIL1 mutations [6, 23] were examined. In addition, 
sciatic nerve specimens derived from woozy [15] (3 animals aged 16 weeks and 3 animals aged 
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26 weeks) and wildtype mice (3 animals aged 16 weeks and 3 animals aged 26 weeks) were 
fixed in 3.9 % buffered glutaraldehyde. Samples were osmicated in 1 % phosphate-buffered 
osmium tetroxide, dehydrated and embedded in epoxy resin. Ultrathin sections (100 nm) of 
transversely and longitudinally embedded nerve fascicles were contrasted with uranyl acetate 
and lead citrate. EM images were obtained using a CM10 transmission electron microscope 
(Philips, Amsterdam, The Netherlands). 
 
Proteomic profiling 
Tissue lysis and carbamidomethylation 
Sciatic nerves derived from three woozy and three wild-type animals were used for comparative 
proteome profiling utilizing a label-free approach. Each sample was ground and lysed in 0.5 mL 
of 50 mM Tris-HCl (pH 7.8) buffer containing 150 mM NaCl, 1 % SDS and Complete Mini. 
Afterwards, extracts were centrifuged at 13,500 x g for 30 min at 4 °C and protein lysate was 
collected. The protein concentration of each sample was determined by BCA assay according to 
the manufacturer’s protocol. Then, cysteines of the proteins were reduced by addition of 10 mM 
DTT at 56°C for 30 min, followed by alkylation of free thiol groups with 30 mM IAA at room 
temperature (RT) in the dark for 30 min. 
Sample preparation and trypsin digestion 
Sample preparation and proteolysis were performed using filter-aided sample preparation 
(FASP). Briefly, 100 µg of protein was diluted 10-fold with freshly prepared 8 M urea/100 mM 
Tris-HCl (pH 8.5) buffer and placed on a centrifugal device Nanosep 30 KDa Omega (Life 
Science). The device was centrifuged at 13,800 g at RT for 20 min for all centrifugation steps. 
First, to eliminate residual SDS, three washing steps were carried out with 100 µL of 8 M 
urea/100 mM Tris-HCl (pH 8.5). Then, for buffer exchange, the device was washed thrice with 
100 µL of 50 mM NH4HCO3 (pH 7.8). Next, 100 µL of proteolysis buffer comprising of trypsin 
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(Promega) (1:25 w/w, protease to substrate), 0.2 M GuHCl and 2 mM CaCl2 in 50 mM NH4HCO3 
(pH 7.8), was added to the device and incubated at 37°C for 14 h. Afterwards, the generated 
tryptic peptides were recovered by centrifugation with 50 µL of 50 mM NH4HCO3 followed by 50 
µL of ultra-pure water. Finally, peptides were acidified by addition of 10 % TFA (v/v) and digests 
were quality-controlled in a reversed-phase HPLC. 
LC-MS/MS analysis  
Replicates were measured using an UltiMate 3000 nano RSLC System coupled to a Lumos 
Dionex Mass Spectrometer (both from Thermo Scientific). Peptides were preconcentrated on a 
100 µm x 2 cm, C18, 5 µm, 100 Å trapping column for 10 min using 0.1 % TFA (v/v) at a flow 
rate of 20 µL/min followed by separation on 75 µm x 50 cm, C18, 2 µm, 100 Å main column 
(both from Acclaim Pepmap, Thermo Scientific) with a 120 min LC gradient ranging from 3-35 % 
of 84 % ACN, 0.1 % FA (v/v) at a flow rate of 250 nL/min. MS survey scans were acquired in the 
Orbitrap from m/z 300 to 1500 at a resolution of 120,000 using the ambient air (protonated 
(Si(CH3)2O))6) ion at m/z 445.12002 as lock mass [24]. The most intense signals were 
subjected to high collision induced dissociation (HCD), and the detection was archived in the ion 
trap, taking into account a dynamic exclusion of 30 s. HCD spectra were acquired with a 
normalized collision energy of 30 % and an activation time of 10 ms. AGC target values were 
set to 2 x 106 for Orbitrap MS and 2 x 104 for ion trap MSn scans. Maximum injection times were 
set to 50 ms and 300 ms for both full MS and MSn scans, respectively. 
Label free data analysis 
Data analysis of the acquired label free quantitative MS data was performed using the 
Progenesis Qi software from Nonlinear Dynamics (Newcastle upon Tyne, U.K.) in which 
alignment of MS raw data was conducted by automatically selecting one of the LC-MS files as 
reference. After peak picking, only features within retention time and m/z windows from 0-120 
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min and 300-1500 m/z, with charge states +2, +3, and +4 were considered for peptide statistics 
and analysis of variance (ANOVA). MS/MS spectra were exported in an mgf file as peak lists. 
The mgf peak lists were searched against a concatenated target/decoy version of the mouse 
Uniprot database, (downloaded in July 2015, containing 16,716 target sequences) using Mascot 
2.4.0 (Matrix Science), X! TANDEM Vengeance (2015.12.15.2) and MS-GF+ Beta (v10282) 
(12/19/2014) with the help of searchGUI 2.8.4. Trypsin with a maximum of two missed 
cleavages was selected as enzyme. Carbamidomethylation of cysteine was set as fixed and 
oxidation of methionine was selected as variable modification. MS and MS/MS tolerances were 
set to 10 ppm and 0.5 Da, respectively. 
PeptideShaker software 1.10.2 was used for interpretation of peptide and protein identifications 
from searchGUI and Mascot. Combined search results were filtered at a false discovery rate 
(FDR) of 1 % on the protein level and exported using the advanced PeptideShaker features that 
allow direct re-import of the quality-controlled data into Progenesis Qi. Peptide sequences 
containing oxidized methionines were excluded for further analysis. Only proteins that were 
quantified with unique peptides were exported. Then, for each protein, the average of the 
normalized abundances (obtained from Progenesis Qi) from the replicate analyses was 
calculated to determine the ratios between the woozy and the wildtype mice. Only proteins 
which were (i) commonly quantified in all the replicates with (ii) at least a unique peptide, (iii) an 
ANOVA p-value of <0.05 (Progenesis Qi) and (iv) an average log2 ratio of which protein that 
was either higher than the up-regulated cut-off or lower than the down-regulated cut-off was 
considered as regulated. The cut-off values were determined based on the 2x standard 
deviation and the normal distribution from all identified protein’s log2 ratio in which the bell curve 
is symmetric around the mean. Therefore, an average log2 ratio of a protein which < -1.02 or > 
1.05 (corresponding to ~2.09-fold regulation; log2 ratios of 1.01) for comparative global profile 
were considered as regulated. 
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Morphological studies of neuromuscular junctions in woozy mice 
Immunofluorescence staining of 100 µm-thick free-floating longitudinal sections of Extensor 
Digitorum Longus muscles were done as previously described [25]. Briefly, muscles were 
incubated in 1x PBS/0.5 % Tween-20 with 10 µg/mL Heparin (1x PTwH) for 24 h at room 
temperature. Then, muscles were transferred to 1x PBS/1x PTwH/0.5 % Triton X-100/10 % 
(vol/vol) DMSO/6 % (vol/vol) BSA (1x BnP) at room temperature for 5 days. Followed by 
incubation with Bungarotoxin 647 (Invitrogen/B35450) in 1 × BnP solution for 5 d at 37 °C. After 
the staining, muscles were washed with PTwH solution for 5d at RT before imaging. Muscles 
were placed in a 35mm glass bottom dish and imaged with an inverted Leica SP2 (Leica 
Microsystems, Mannheim, Germany) confocal microscope equipped with a HC PL APO 
20x/0.75 IMM CORR UV objective. 3D stacks were taken at 8-bit, 1024x1024 pixel resolution, 
and 400 Hz scan frequency. Images were electronically processed using ImageJ software (NIH, 
Bethesda, MD). NMJ area was determined using the region of interest (ROI) upon thresholding 
at 30 – 255 greyscale values. 
 
Transcript studies in Sil1-mutant and wildtype mice 
To further examine the integrity of the NMJ gene expression investigations were performed for 
targets previously shown to be involved in NMJ structure [26]. RNA was extracted from the 
muscle of 26-week-old mice. TRIzol Reagent (Ambion), 0.1 mL per 50-100 mg of muscle 
weight, was added to each sample. The samples were homogenised on ice using a 
TissueRuptor (Qiagen) and incubated for 5 min at room temperature before centrifuging for 10 
min at 12,000g (4°C). 0.2 mL of Chloroform per 1 mL of Trizol was added to the cleared 
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homogenate solution and the sample vigorously shaken by hand for 15 sec. Samples were 
incubated for 3 min at room temperature, centrifuged for 15 min at 12,000g (4°C), and the RNA 
in the aqueous phase transferred to a new tube. 0.5 mL per 1mL of Trizol of isopropyl alcohol 
was added to each sample which was again shaken by hand before incubation at room 
temperature for 10 min. Samples were centrifuged for 15 min to obtain the RNA pellet, which 
was then washed in 75% ETOH and centrifuged for 5 min. The supernatant was removed, and 
the pellet dried in a heat block at 55-60°C.The RNA was re-suspended in RNAase-free-water 
(Ambion)and incubated at 55-60°C for 10 min. Sample purity (A260/A280 ratio) and concentration 
(µg/µl) were assessed using a Nanodrop2000 (ThermoFisher). 
DNAase treatment and reverse transcription was performed according to manufacturer’s 
instructions using the DNA-free™ DNA Removal Kit (ThermoFisher) and the High-Capacity 
cDNA Reverse Transcription Kit (ThermoFisher) respectively. Samples were stored at -20°C 
until use. 
Real-time PCR (qPCR) was performed on a BioRad CFX96 using Power SYBR Green Master 
Mix (ThermoFisher). For each gene examined, a temperature gradient and dilution calibration 
curve were performed to determine optimum conditions for the primer pair (Table 1) and check 
the reaction efficiency. A master mix composed of 10µL of SYBR Green, 6µL of DEPC-H2O, 
1µL of forward and reverse primer (Table 1) was added to 2µL of cDNA. Samples were run in 
triplicate along with a no-template control (NTC), with only wells that were at least 3 Cq cycles 
away from the NTC being used for analysis. Data was analysed using the ΔΔCq method. 
Gene Forward Sequence Reverse Sequence Annealing 
temp (°C) 
NCBI Ref 
AChRγ 
[26] 
GACCAACCTCATCTCCCTGA GAGAGCCACCTCGAAGACAC 60 NM_009604.3 
NCAM 
[26] 
AAGGGGAAGGCACTGAATTT TCTCCTGCCACTTGACACAG 60 NM_001081445.1 
AchRα 
[26] 
TCCCTTCGATGAGCAGAACT GGGCAGCAGGAGTAGAACAC 60 NM_007389.5 
NGF 
[26] 
GCAGTGAGGTGCATAGCGTA CTGTGTCAAGGGAATGCTGA 60 NM_001112698.2 
TATA TGCCCAGCATCACTATTTCA CCGTAAGGCATCATTGGACT 60 NM_013684.3 
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BOX BP 
[26] 
AchRε 
[26] 
GCAGCTTTTACCGAGAATGG CGTCAGTTTCTCCAGGACC 60 NC_000077.6 
MuSK 
[26] 
TTCAGCGGGACTGAGAAACT TGTCTTCCACGCTCAGAATG 61.5 NM_001037127.2 
BDNF 
[26] 
TAATGCAGCATGATGGGAAA TCACAGTGAAAGCACCTTGC 60 NM_001048139.1 
NGF 
[26] 
GCAGTGAGGTGCATAGCGTA CTGTGTCAAGGGAATGCTGA 60 NM_001112698.2 
NTRK2 
[27] 
CGGCACATAAATTTCACACG GTGAGGTTAGGAGCAGCCAG 63.9 NM 008745.2   
NTRK3 
[27] 
AAGTAACCGGCTCACCACAC GATGCAGTAAAGGCTCTGGC 63.9 NM_182809.2 
P75 [27] CAACCAGACCGTGTGTGAAC GAGAACACGAGTCCTGAGCC 63.9 NM 033217.3 
Table 1: Oligonucleotides used for the transcription studies 
 
Generation of a MSS-zebrafish model and studies of NMJ integrity and myelination 
To examine NMJ integrity and myelination, knockdowns were performed in zygotes of the 
Golden (slc24a5b1/+) Danio rerio strain (ZIRC, OR, USA). Zebrafish embryos and larvae were 
raised and staged according to standard procedures [28].  
Antisense morpholino oligonucleotides (MOs) were purchased from Gene Tools (Pilomath, OR). 
We obtained a previously published [33] Sil1 splice-blocking MO directed against the splice 
acceptor site of exon 2 (5’- GGTGACTGTGTAAACAGAACAAATC-3’). The Gene Tools 
standard control-MO targeting a human β-hemoglobin gene (5′-
CCTCTTACCTCAGTTACAATTTATA-3′) was used as a negative control for the effects of MO 
injection. Zygotes were injected with 6ng of either Sil1 MO or control-MO following standard 
protocols. 
Bright field microscopy images of larvae were captured using a Leica dissection 
stereomicroscope equipped with a Leica digital camera (model DFC 420C). For 
immunofluorescent staining of whole mount zebrafish, 5-day post fertilization zebrafish embryos 
were dechorionated using Pronase E (Sigma Aldrich) and euthanized by anesthetic overdose. 
Whole mount staining was performed as described previously [29], utilizing a mouse anti-SV2 
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antibody to visualize the motor neurons (1:200, Developmental Studies Hybridoma Bank) and 
Alexa Fluor 594-α-bungarotoxin conjugate to visualize acetylcholine receptors (1:1000, Thermo 
Fisher). A Claudin K antibody (1:200) was used for myelin-staining. Z-stack images 
encompassing the entire zebrafish tail were obtained using a 20x air objective on a Nikon A1R 
confocal microscope.  
 
Results 
Electron microscopy  
EM of intramuscular nerves found in quadriceps muscles of MSS patients revealed 
accumulations of membranous autophagic/mitophagic material as well as spheroid-like 
accumulations of cytoskeletal elements and of organelles associated with a thinning of the 
myelin sheaths in axons; a similar buildup of autophagic material was also present in Schwann 
cells of myelinated and unmyelinated nerve fibers (Fig. 1).  
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Figure 1: EM of intramuscular nerve fibres in MSS patient skeletal muscle. (A, B) Membranous material and 
swollen/degenerated mitochondria (white arrows) and nuclear envelope widening combined with chromatin 
condensation in Schwann cells (grey arrows). (C, D) Spheroid-like accumulation of cytoskeletal elements and of 
organelles associated with a thinning of the myelin sheaths. The nerve fibre depicted in (D) is surrounded by a 
surplus Schwann cell process. (E) Autophagic material (black arrow) in an unmyelinated axon. (F) Autophagic 
material (black arrows) in the cytoplasm of a Schwann cell; swollen mitochondria in unmyelinated axons (white 
arrows).  
 
Similar alterations were found in quadriceps intramuscular nerves of 26-week-old (Fig. 2) and in 
sciatic nerves of 16 and 26-week-old woozy mice (Figs. 3, 4) but not in nerves derived from 
respective wildtype littermates (data not shown). In addition, prominent widenings of the space 
between the inner and the outer leaflets of the nuclear envelope in Schwann cells was observed 
in MSS-patients and these mice; these vacuolar structures often contained granular or 
membranous electron-dense material (Figs. 1, 2). Aberrant, often widened endoplasmic 
reticulum structures were observed in both human patient and woozy mouse Schwann cells 
(Figs. 1-4). Axons with disproportionately thin myelin sheaths could be occasionally found in 
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both, MSS-patients and woozy mice (Figs. 1-3). Notably, even though the deposits of electron 
dense autophagic material became more prominent in myelinated and non-myelinated axons 
(11% in 16-week-old and 21% in 26-week-old mutant animals on average) as well as in 
Schwann cells in 26-week-old animals (10% in 16-week-old and 16% in 26-week-old mutant 
animals on average) (Figs. 3, 4), the mild perturbations of myelination did not increase with age. 
Perturbations of the nuclear envelope are detectable in 7% of Schwann cell nuclei on average. 
The mitochondrial changes occurred with 12% on average in the PNS of 16-week-old mutant 
mice and with 26% on average in the PNS of 26-week-old woozy animals. 
 
Figure 2: Ultrastructural alterations in 26-week-old woozy mouse intramuscular (quadriceps muscle) nerve 
fascicles. (A, B) Focal widening (grey arrows) of the nuclear envelope of Schwann cells. (C) Spheroid-like swelling 
of a myelinated nerve fiber due to intraaxonal accumulation of cytoskeletal elements and organelles. (D) Swollen 
intraaxonal mitochondria (white arrows). (E, F) Large accumulations of granular and membranous autophagic 
material in the axons and/or in the adaxonal Schwann cell cytoplasm (black arrows). 
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Figure 3: EM of 16-week-old control and woozy mouse sciatic nerves. (A, B) Normal control nerve fibres. (C, D) 
Membranous cytoplasmic bodies (black arrows) in woozy mouse nerve fibres. (E, F) Prominent ER/Golgi structures in 
the cytoplasms of Schwann cells of myelinated fibres (grey arrows) and degenerating mitochondrion (white arrow). G 
Autophagic vacuole in a Schwann cell (black arrow). (H) Disproportional thin myelinated axons and (H, I) prominent, 
swollen intraaxonal mitochondria (white arrows). 
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Figure 4: Ultrastructural findings in sciatic nerves of 26-week-old woozy mice. (A) and inset in (A) degenerating 
unmyelinated axon in Remak bundle. (B, C) Accumulations of autophagic material in axons of myelinated nerve 
fibres. (D, E, F) Invaginations of the axolemma associated with accumulated autophagic material within the axons 
and in the adaxonal Schwann cell cytoplasm. (G) Autophagic vacuoles containing membranous material in the 
cytoplasm of a Schwann cell of a myelinated nerve fibre (black arrows). (H-J) Prominent ER structures (grey arrows) 
merging with membranous autophagic material (black arrows) in the cytoplasm of Schwann cells. 
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SIL1 deficiency perturbs integrity of neuromuscular junctions in woozy mice and MSS 
zebrafish 
Prompted by our previous observation that in woozy  mice, integrity of the NMJs is disturbed 
and that this is associated with signs of neurogenic atrophy of muscle fibers [18], we 
investigated NMJs in extensor digitorum longus muscles from 26-week-old woozy and wild-type 
mice and in a MSS-zebrafish model. Morphological investigation of a total of 100 NMJs stained 
with bungarotoxin revealed a statistically significant reduction in the size of NMJs in the woozy 
animals (Fig. 5A, B). Moreover, in mutant mice, the fluorescence intensity of α-bungarotoxin 
appeared weaker thus suggesting reduced presence of AChR compared to wildtype NMJs (Fig. 
5A). Immunofluorescence of NMJs in zebrafish Sil1 morphants illustrated a disruption of 
synapse formation along the vertical myosepta with a striking disorganization of presynaptic 
branching across the muscle fibres of the myotomes compared to those observed in control fish 
(Fig. 6A). Further studies of myelinating Schwann cells using a Claudin K antibody did not show 
significant differences between control-morpholino and Sil1-morpholino injected fish (Fig. 6B). 
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Figure 5: NMJ-analysis of Sil1-mutant and wild-type mice (26 weeks of age). (A) Visualization of NMJs via 
fluorescence-dye conjugated α-bungarotoxin binding to acetelycholine receptors revealed an overall reduced 
fluorescence intensity in the mutant animals compared to control suggesting reduced level of the receptor upon SIL1-
deficiency. (B) Analysis of the size of wildtype and SIL1-mutant NMJs. (C) Studies of abundances of transcripts 
encoding for de-innervation (AChRα, AChRε, AChRγ, Musk, NCAM) and re-innervation markers (BDNF, NGF, 
NTRK2, NTRK3, p75) revealed significantly increased abundances of AChRγ and NCAM transcripts in Sil1-mutant 
animals compared to wildtype littermate controls. AChR = acetelycholine receptors; Musk = muscle, skeletal receptor 
tyrosine-protein kinase; NCAM = neural cell adhesion molecule; brain-derived neurotrophic factor; NGF = β-nerve 
growth factor; NTRK = high affinity nerve growth factor receptor; p75 = low affinity neurotrophin receptor p75NTR. 
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Figure 6: Immunofluorescence studies in 48 hpf MSS-zebrafish. (A) Immunofluorescent studies of NMJs in 
control-MO (6A) & Sil1-MO (6B) injected embryos (6ng of MO-injection respectively). SV2 stains presynaptic motor 
neurons and α-bungarotoxin detects the postsynaptic AChRs. Sil1-MO injected fish display disorganised branching of 
nerves and of synapses along the vertical myosepta. MO=morpholino, hpf = hours post fertilisation, AChRs = 
acetelycholine receptors, SV2 = synaptic vesicle protein 2. (B) Staining of myelinating Schwann cells utilizing an anti-
Claudin K antibody did not show significant differences between wildtype, control-morpholino (CMO) and Sil1-
morpholino-injected fish (6C). Scale bar = 20 µm. 
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Gene expression analysis of de-innervation and re-innervation 
The gene expression analysis of de-innervation and re-innervation markers, performed on Sil1 
mutant and wildtype mice, revealed significant changes supporting the concept of perturbed 
NMJ integrity and function: among the investigated de-innervation markers, transcripts of 
AChRγ and N-CAM were respectively 36.05-fold and 3.58-fold higher in mutant than in wildtype 
animals whereas the other transcript marker (AChRα, AChRε, MuSK) values were not 
statistically significant changed in abundances. Re-innervation transcript markers (BDNF, NGF, 
NTRK2, NTRK, p75) did not show significant changes in transcript abundances (Fig. 5D).  
 
SIL1-mutant sciatic nerves display changes in protein abundances 
Proteomics is a powerful tool for the unbiased investigation of pathophysiological processes [30, 
31]. Here, we compared Sil1-mutant and wildtype sciatic nerves using quantitative mass 
spectrometry. We found that 1.22% of the quantified proteins (20 out of 1632) were differentially 
expressed upon loss of functional SIL1 in this tissue: 15 (0.92%) of these proteins were 
upregulated and 5 (0.3%) downregulated (Fig. 7A-C). The affected proteins are located to the 
cytoplasm, cellular membranes and the extracellular space (Fig. 7D). For an overview on the 
regulated proteins and proposed functions, see supplemental table 1. To provide insight into 
SIL1 neuronal cytopathology, the spectrum of affected proteins was analyzed for enriched gene 
ontology (GO) terms using STRING [32] (Suppl. Fig. 1).  
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Figure 7: Proteomic profiling of Sil1-mutant nerves. (A) Applied workflow. (B) Volcano plot of obtained proteomic 
results. (C) Diagram presenting the fold of protein-dysregulation and the function of the affected proteins. (D) 
Schematic presentation of the subcellular localization of the proteins altered in abundances upon the loss of 
functional SIL1 in murine sciatic nerves.  
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Discussion 
PNS is vulnerable against the loss of SIL1 
Recessive SIL1 mutations cause MSS in human patients and the woozy phenotype in mice [13, 
15, 23], both with degeneration of Purkinje cells and ataxia. Some MSS patients present with 
additional Dandy-Walker syndrome [9], spastic paraplegia [10] or motor neuronopathy 
associated with bradykinetic movement disorder [11]. Moreover, Sil1 knock down in zebrafish by 
two different antisense oligo morpholinos resulted in loss of Purkinje cells [33]. Hence, a 
profound role of SIL1 in neuronal function and maintenance can be postulated. This assumption 
is also supported by the crucial role of (functional) BiP levels for motor neuron survival [34] and 
observations that SIL1 elevation (i) attenuates motor neuron vulnerability in a mouse model of 
ALS [18] and (ii) triggers the expression of proteins with neuroprotective properties [20]. To 
address the vulnerability of the PNS against SIL1 loss, we performed combined electron 
microscopic, immunofluorescence, proteomic and selected transcript studies. Results of our 
ultra-morphological studies on intra-muscular nerve fascicles from two MSS-patients and three 
woozy and wildtype mice revealed affection of myelinating and non-myelinating Schwann cells 
as well as of axons engulfed by both types of Schwann cells. Hereby, changes in the 
architecture of the nuclear envelope were observed accompanied by mitochondrial 
degeneration and aggregates of autophagic material. These aggregates were remarkably 
prominent in myelinated axons of Sil1-mutant mice and were found to be more pronounced in 
26- compared to 16-week-old animals. Interestingly, abnormal aggregates of autophagic 
material and perturbations of nuclear envelope structures as well as mitochondrial degeneration 
have already been extensively described in MSS-patient and woozy mouse muscle as well as in 
in vitro models of the disease [13, 21] suggesting that these ultra-morphological changes are a 
consistent feature in tissues vulnerable for SIL1 loss. Moreover, this finding is in line with the 
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results of a study linking levels of functional BiP to the activation of autophagy as a mechanism 
acting towards the breakdown of protein aggregates and to axonal degeneration [34].  
The major differential diagnosis of MSS is the congenital cataracts, facial dysmorphism and 
peripheral neuropathy (CCFDN) syndrome due to a recurrent recessive mutation in CTDP1. 
CCFDN is associated with a symmetric, distal peripheral neuropathy with a predominant motor 
phenotype. Secondary scoliosis and foot deformities are common. Sensory neuropathy 
develops after age ten years [35]. Interestingly, scoliosis has also been described in 61% of 
patients with SIL1 mutations [36]. Our present findings suggest that MSS is phenotypically even 
more reminiscent to CCFDN, as neuropathy appears to be a consistent feature of SIL1 mutation 
in patients and mice. However, the buildup of autophagic material in MSS and woozy mice was 
present predominantly in axons, whereas the neuropathy in CCFDN was described to be 
hypo/demyelinating [35] . Moreover, myelination also seemed to be normal in the MSS-
zebrafish model. 
NMJs are vulnerable to the loss of SIL1 
Axonal neuropathies often go along with defects of neuromuscular junctions (NMJs) [37]. 
Therefore, we sought to determine whether perturbed NMJ integrity is a pathophysiological 
aspect of SIL1 deficiency. Immunofluorescence of NMJs in woozy mice revealed smaller NMJs 
and weaker fluorescence intensity for α-bungarotoxin, suggesting reduced presence of 
acetylcholine receptor (AChR) subunits. Immunofluorescence of our MSS zebrafish model 
confirmed impaired NMJ integrity, supporting our findings obtained in woozy mice and 
demonstrating that this pathophysiological feature manifests across different species. 
Alterations of AChR density might, at least partially, result from a disturbed SIL1-BiP machinery 
involved in the folding of muscle membrane proteins such as AChRs. In this context, it is 
important to note that agrin which is secreted by axon endings and crucial for clustering of 
AChRs is also itself a substrate of a neuronal SIL1-BiP machinery. Our findings confirm our 
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previous report of perturbed NMJ integrity in woozy mice [18], and indicate that impairment of 
neuromuscular transmission is part of MSS pathophysiology. The concept of a pre- and post-
synaptic impact is supported by results of our proteomic studies (discussed below in more 
detail) showing that gephyrin, a synapse/ NMJ-associated protein [38] is affected by Sil1-
muation in murine sciatic nerves and by results of our targeted skeletal muscle transcript studies 
showing that NCAM as well as AChRγ display altered transcript abundances. Neural cell 
adhesion molecule (NCAM) plays a crucial role in the development and maturation of NMJs and 
is required for stability of re-innervated NMJs also by acting as a signal for regenerating axons 
[39]. Thus, the NCAM increase most likely is a compensatory mechanism preventing NMJs from 
complete breakdown in MSS. The strong increase of AChRγ transcript levels might also 
compensate for decreased AChR presence at the NMJs.  
Proteomic changes in sciatic nerves of woozy mice allow molecular insights into PNS 
vulnerability 
To obtain biochemical insights into PNS vulnerability upon SIL1-loss, comparative proteome 
profiling via a label-free approach was performed. To this end, the proteomic signature of SIL1-
deficient sciatic nerve was examined utilizing three biological replicates derived from woozy and 
wildtype animals aged 26 weeks. Some of the proteins found to be affected prominently such as 
perilipin are major regulators of lipid homeostasis which is important for mitochondrial integrity 
and function [40-43]. Pyruvate carboxylase (PYC) is a mitochondrial protein catalyzing ATP-
dependent carboxylation. As fatty acid oxidation can be attenuated by PYC-inhibition, a 
decrease in SIL1-mutant nerves most likely serves as a protective mechanism. However, 
vulnerability of PYC activity in both non-synaptic and synaptic mitochondria against cellular 
stress burden has been demonstrated [44] suggesting that decreased abundance of PYC in 
SIL1-mutant nerve might correspond with mitochondrial perturbations on the morphological level 
as well as with impaired function of the NMJs discussed above.  
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Mitochondrial defects promote ROS production [45], a fact which is in line with the detected 
increase in antioxidant factors upon SIL1 deficiency, exemplified by the up-regulation of 
Murinoglobulin-1 (MUG1), Serine protease inhibitor A3K (SA3K), Chloride intracellular channel 
protein 6 (CLIC6), Alpha-1-antitrypsin 1-5 (A1AT5), Thymosin beta-4 (TYB4) and Copper 
transport protein ATOX1 [46-48]. Interestingly, TYB4 improves neurological functional outcome 
and axonal remodeling after embolic stroke in rats also suggesting a neuroprotective function of 
this protein [49]. EGFR promotes intrinsic axonal regeneration [50]. Similarly, as purine 
nucleoside phosphorylase (PNPH) deficiency results in a disorder characterized by recurrent 
infections, neurologic symptoms (rigid muscles, ataxia, developmental delay, and intellectual 
disability) [51, 52], its increased abundance in Sil1-mutant PNS may also be a protective 
mechanism. Collagen nerve guides support axonal regeneration of the peripheral nerve [53] and 
COL1A1 and COL1A2 have been identified with increased abundance in woozy nerves. 
Gephyrin is well known to promote nerve survival by establishing synaptic specificity at the 
NMJs [54]. Periostin (POSTN) has been identified to play a key role in axonal regeneration [55]. 
Additionally, secreted POSTN has been shown to promote nerve regeneration in patients with 
peripheral neuropathies [56]. Therefore, the down-regulation of POSTN in the global profile 
either hints for an increasing activity of secreted POSTN in the extracellular space in axonal 
regeneration or contributes to axonal vulnerability. However, increased abundance of proteins 
with protective potential does not only indicate a vulnerability of the PNS against loss of 
functional SIL1, but also might explain why PNS pathology is subtle compared to cerebellar and 
skeletal muscle phenotype. In this context, it is worth noting that recently one of our molecular 
studies on organ vulnerability in MSS suggested that the presence of antagonizing factors 
modifies the vulnerability of cells/ tissues against loss of functional SIL1 [57]. 
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Conclusion 
Results of our combined morphological and biochemical studies suggest that the PNS along 
with the NMJs are vulnerable to SIL1-deficiency in human, mouse, and zebrafish. Only few 
nerve fibers showed disproportionately thin myelin sheaths. In contrast, axonal mitochondria 
seem to be affected by the loss of SIL1, and the build-up of autophagic material in axons is 
progressive. Up-regulation of proteins supporting axonal survival not only support the concept of 
PNS vulnerability to SIL1-loss but might also explain why other cellular populations are more 
vulnerable. Moreover, our findings highlight that the presence of PNS pathology might be added 
to the spectrum of MSS and should be considered when delineating MSS from CCFDN in the 
clinical setting. 
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Supplemental Figure 1: STRING-network analysis of proteomic findings. 
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Note:  Green: up-regulated protein 
Red: down-regulated protein 
Accession 
number 
Name Subcellular 
localization 
Function Ref. 
O88492 
 
Perilipin 4 Cell 
membrane, 
lipid droplet 
Formation of lipid droplets (LDs) by coating their 
surface and selectively recruiting lipases and other 
proteins. Inactivation of PLIN4 reduces LD 
accumulation in mice. 
[1, 2] 
Q9DBL9 
 
1-acylglycerol-3-
phosphate O-
acyltransferase 
(ABHD5) 
Lipid droplet Accumulation of ectopic fat by activating ATGL. 
Interaction of ABHD5 with ATGL and the 
mitochondrial PLINs at LD surface enhances 
mitochondrial LD accumulation. 
[3, 4] 
Q05920 
 
Pyruvate 
carboxylase, 
mitochondrial 
(PYC) 
 
Mitochondria PYC decrease causes ATP deficit leading to 
decrease of cytochrome c oxidase activity and 
oxidative phosphorylation in turn resulting in a severe 
mitochondrial damage. However, in response to 
reduction of ATP production, the energy sensor AMP-
activated protein kinase (AMPK) pathway is activated 
and inhibits energy-consuming processes including 
protein, carbohydrate and lipid biosynthesis by 
inactivating lipid metabolic enzymes such as acetyl-
CoA carboxylase (ACACA and ACACB). 
[5, 6] 
P07759 
 
Serine protease 
inhibitor A3K 
(SA3K) 
Secreted Protecting cells against oxidative stress. SA3K also 
elevates SOD, a key antioxidant factor of ROS.  
Furthermore, SA3K inhibits NADPH oxidase 4 
(NOX4) which functions in catalyzing the reduction of 
molecular oxygen to ROS.  
[7, 8] 
Q00898 
 
 
Alpha-1 
antitrypsin (AAT) 
Secreted Mutant AAT or AAT deficient mice show 
inflammation, high ROS-level and a more oxidized, 
cellular redox state. Moreover, AAT injection/ 
overexpression can not only inhibit oxidative stress 
but also promote proliferation and migration and 
suppress apoptosis. 
[9-11] 
 Thymosin beta-4 
(Tβ4) 
cytoskeleton Regulates multiple cell signalling pathways related to 
cell proliferation, differentiation and modulation of 
inflammatory mediators by targeting the antioxidant 
SOD enzymes and increasing their expression 
[12, 13] 
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therefore reducing the intracellular ROS level. 
Moreover, Tβ4 can increase expression of catalase 
enzymes and thus protects cells against oxidative 
damage. In addition, Tβ4 is an actin sequestering 
protein and thus plays a role in organisation of 
cytoskeleton. 
P28665 
 
Murinoglobulin-1 
(MUG1) 
Secreted MUG1 is an inhibitor for Neuropsin , a protein 
responsible for visual and non-visual photoreception. 
Notoriously, inactivation of Neuropsin has a positive 
effect against stress and promoting synaptic 
plasticity. 
[14, 15] 
Q8BHB9 
 
Chloride 
intracellular 
channel protein 6 
(CLIC6) 
Cell 
membrane 
CLIC6 has an antioxidant effect by interacting with 
dopamine D receptors. Moreover, a transcriptome 
study on chronic mild stress (CMS) linked CMS to 
deregulation of genes such as CLIC6 involved 
in dopamine receptor mediated signaling pathway. 
Hence, the up-regulation of CLIC6 in woozy nerves 
might accord with stress protection. 
[16] 
O08997 
 
Copper transport 
protein ATOX1 
(ATOX1) 
Cytoplasm ATOX1, an antioxidant copper chaperone, binds and 
transports cytosolic copper to copper transporting 
ATPase proteins (such as ATP7A) in the trans-Golgi 
network and various endocytic vesicles. This 
maintains copper levels in cytosol and mitochondria 
which is required for maturation of cytochrome c 
oxidase. ATOX1 deficient mice have lower SOD 
activity due to low efficiency of copper loading. Many 
studies demonstrated protective functions of ATOX1 
against hydrogen peroxide-induced oxidative damage 
and the inactivation of ATOX1 greatly increases cell 
sensitivity to stress. 
[17] 
Q01279 
 
Epidermal 
growth factor 
receptor EGFR  
Cell 
membrane 
EGFR promotes axonal regeneration via modulation 
of the neuronal intrinsic regenerative ability. 
[18] 
P23492 
 
Purine 
nucleoside 
phosphorylase 
(PNPH) 
Cytoplasm PNPH cleaves inosine into hypoxanthine and ribose-
1-phosphate which is necessary for many essential 
biochemical processes in the nervous system. It has 
been shown that the uric acid hypoxanthine induces 
axonal growth and has antioxidant effects in multiple 
sclerosis, stroke, and other neurodegenerative 
diseases. 
[19, 20] 
Q9EQ80 Putative GTP Cytoplasm, NIF3L1 negatively regulates expression of genes [21] 
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 cyclohydrolase 1 
type 2 NIF3L1 
nucleus involved in neuronal differentiation. Hence, its 
decrease suggests promotion of expression of 
differentiation-related genes in woozy nerves. 
Q8BUV3 
 
Gephyrin 
(GEPH) 
Cell junction, 
synapse 
Microtubule-associated protein involved in membrane 
protein-cytoskeleton interactions. Anchors the 
inhibitory glycine receptor (GLYR) to subsynaptic 
microtubules. Its increase might accord with a cellular 
strategy compensating the vulnerability of the NMJs. 
[22, 23] 
Q62009 
 
Periostin 
(POSTN) 
Secreted, 
extracellular 
matrix 
Expressed in Schwann cell precursors and Schwann 
cells, and is particularly high in migratory Schwann 
cells. Stimulation of Schwann cells with NRG1 or 
TGFβ-1 results in elevated periostin expression. 
Astroglial-derived periostin promotes axonal 
regeneration after spinal cord injury thus suggesting a 
protective effect of this secretory protein. 
[24, 25] 
Q01149 
 
Collagen alpha-
2(I) chain 
(CO1A2) 
 
Secreted, 
extracellular 
matrix 
Impaired extracellular matrix (ECM) degradation 
perturbed nerve regeneration and the transformation 
into a mature ECM is necessary for efficient nerve 
regeneration. Upregulation of collagens is supported 
by increase of the serine protease inhibitor AAT 
which degrades many extracellular matrix 
components such as elastin, collagens and 
fibronectin. 
[26-29] 
P11087 
 
Collagen alpha-
1(I) chain 
(CO1A1) 
 
Secreted, 
extracellular 
matrix 
  
P31428 
 
Dipeptidase Cell 
membrane 
Hydrolyzes a wide range of dipeptides and modulates 
cell proliferation  
http://w
ww.unip
rot.org 
Supplemental Table 1: Description of subcellular localization and function of proteins affected by SIL1-deficiency in 
murine sciatic nerve. 
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Highlights: 
 
- Electron microscopic studies identified vulnerability of the peripheral nervous system 
against the loss of functional SIL1 by the build-up of protein aggregates, perturbations of 
the nuclei of Schwann cells and mitochondrial degeneration 
- Proteome profiling of sciatic nerve specimens from woozy mice revealed altered levels 
of proteins implicated in neuronal maintenance suggesting the activation of 
compensatory mechanisms 
- Perturbed integrity of the neuromuscular junctions (NMJs) could be identified upon the 
loss of functional SIL1 in mice and zebrafish 
- Results of transcript studies support the concept of NMJ-vulnerability against SIL1-loss 
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